2020 MIPS Measure #066: Appropriate Testing for Children with Pharyngitis

Measure Type High Priority Measure? Collection Type(s)
Process yes eCQM, MIPS CQM

Measure Description

Percentage of children 3-18 years of age who were diagnosed with pharyngitis, ordered an antibiotic and received a group A streptococcus (strep) test for the episode 

Stay up to date with the latest news regarding MACRA and MIPS.

The Healthmonix Advisor is a free weekly news source, connecting you to the latest updates in the value-based care industry.


Instructions

This measure is to be submitted once for each occurrence of pharyngitis during the performance period. Claims data will be analyzed to determine unique occurrences. This measure is intended to reflect the quality of services provided for the primary management of patients with pharyngitis who were dispensed an antibiotic. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding. 

Measure Submission Type:

The listed denominator criteria are used to identify the intended patient population. The numerator options included in this specification are used to submit the quality actions as allowed by the measure. The quality-data codes listed do not need to be submitted for registry-based submissions; however, these codes may be submitted for those registries that utilize claims data. 

Denominator

Children 3 – 18 years of age who had an outpatient or emergency department (ED) visit with a diagnosis of pharyngitis during the measurement period and an antibiotic ordered on or three days after the visit

Denominator Instructions:
To determine eligibility, look for any of the listed antibiotic drugs below in the 30 days prior to the visit with the pharyngitis diagnosis. As long as there are no prescriptions for the listed antibiotics during this time period, the patient is eligible for denominator inclusion. 

DENOMINATOR NOTE: *Signifies that this CPT Category I code is a non-covered service under the Medicare Part B Physician Fee Schedule (PFS). These non-covered services should be counted in the denominator population for MIPS CQMs.

Denominator Criteria (Eligible Cases):

Patients aged 3 to 18 years on date of encounter

AND

Diagnosis for pharyngitis (ICD-10-CM): J02.0, J02.8, J02.9, J03.00, J03.01, J03.80, J03.81, J03.90, J03.91

AND

Patient encounter during the performance period (CPT or HCPCS): 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99217, 99218, 99219, 99220, 99241*, 99242*, 99243*,99244*, 99245*, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, 99401*, 99402*,99403*, 99404*, 99411*, 99412*, 99429*, 99455, 99456, 99281, 99282, 99283, 99284, 99285, 99381*, 99382*, 99383*, 99384*, 99385*, 99386*, 99387*, 99391*, 99392*, 99393*, 99394*, 99395*, 99396*, 99397*

AND

Prescribed or dispensed antibiotic: G8711

AND NOT

DENOMINATOR EXCLUSIONS:

Patients who use hospice services any time during the measurement period: G9702

OR

Children who are taking antibiotics in the 30 days prior to the diagnosis of pharyngitis: G9703

OR

Children with a competing diagnosis for Upper Respiratory Infection within three days of diagnosis of pharyngitis (e.g., intestinal infection, pertussis, bacterial infection, Lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/ adenoids, prostatitis, cellulitis, mastoiditis, or bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia/gonococcal infections, venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis or UTI): G2097

Table 1 – Antibiotic Medications

Description

Prescription

Aminopenicillins

Amoxicillin
Ampicillin

Beta-lactamase inhibitors

Amoxicillin-clavulanate 

First generation cephalosporins

Cefadroxil
Cephalexin
Cefazolin 

Folate antagonist

Trimethoprim

Lincomycin derivatives

Clindamycin

Macrolides

Azithromycin
Erythromycin ethylsuccinate
Clarithromycin
Erythromycin lactobionate
Erythromycin
Erythromycin stearate

Miscellaneous antibiotics

Erythromycin-sulfisoxazole

Natural penicillins

Penicillin G potassium
Penicillin V potassium
Penicillin G sodium

Penicillinase-resistant penicillins

Dicloxacillin

Quinolones

Ciprofloxacin
Moxifloxacin
Levofloxacin
Ofloxacin

Second generation cephalosporins

Cefaclor
Cefuroxime
Cefprozil

Sulfonamides

Sulfamethoxazole-trimethoprim

Tetracyclines

Doxycycline
Tetracycline
Minocycline

Third generation cephalosporins

Cefdinir
Ceftibuten
Cefixime
Cefditoren
Cefpodoxime
Ceftriaxone

Numerator

NUMERATOR:

Children with a group A streptococcus test in the 7-day period from 3 days prior through 3 days after the diagnosis of pharyngitis 

Numerator Instructions:
A higher score indicates appropriate treatment of children with pharyngitis (e.g., the proportion for whom antibiotics were prescribed with an accompanying step test).

Numerator Options:

Performance Met:

Group A Strep Test Performed (3210F)

OR

Performance Not Met:

Group A Strep Test not Performed, reason not otherwise specified (3210F with 8P)